NM_015500.2:c.1652C>T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015500.2(C2CD2):c.1652C>T(p.Pro551Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000385 in 1,611,838 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015500.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152108Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000245 AC: 6AN: 244924Hom.: 0 AF XY: 0.0000374 AC XY: 5AN XY: 133652
GnomAD4 exome AF: 0.0000322 AC: 47AN: 1459730Hom.: 0 Cov.: 33 AF XY: 0.0000372 AC XY: 27AN XY: 726226
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152108Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74314
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1652C>T (p.P551L) alteration is located in exon 13 (coding exon 13) of the C2CD2 gene. This alteration results from a C to T substitution at nucleotide position 1652, causing the proline (P) at amino acid position 551 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at